
    
      Primary objective:

      To describe the patient's perception of the impact of ORALAIR® on his/her health related
      generic and disease specific quality of life during the grass pollen season in real-life
      settings.

      Secondary objectives:

      - To describe the patient's perceived effectiveness of ORALAIR® in allergic
      rhinoconjunctivitis management in terms of disease intensity, satisfaction and rescue
      medication
    
  